Trial Profile
Special Drug Use Investigation for Relenza (Zanamivir) (Prophylaxis)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GSK
- 13 Jul 2011 New trial record